UV Phototherapy Device (KZX-308nm-BL65, KZX-308nm-BL55, KZX-308nm-BL50, KZX-308nm-BL45, KZX-308nm-BL35)
Shijiazhuang Recovery Star Medical Device Co., Ltd. · Decision date Oct 5, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-05 for K262285, a traditional 510(k) from Shijiazhuang Recovery Star Medical Device Co., Ltd. The device is listed as a UV Phototherapy Device covering five model designations: KZX-308nm-BL65, KZX-308nm-BL55, KZX-308nm-BL50, KZX-308nm-BL45 and KZX-308nm-BL35. It falls under device classification name Light, Ultraviolet, Dermatological, regulation number 878.4630, product code FTC, with a General & Plastic Surgery review panel and specialty. The application was received 07/06/2026 and was not reviewed by a third party.
SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The public record does not include the predicate device, the specific differences among the five model designations, or any indications, dosing or treatment parameters, so those details remain unknown here. The page lists no combination product and no authorized predetermined change control plan.
The record also does not state whether any of the five models represents a changed item relative to a prior clearance, so the scope of what was reviewed cannot be characterized beyond the listed device name.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 5, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262285
- Regulatory pathway
- 510(k) premarket notification
- Product code
- FTC
- Decision code
- SESE
- Decision date
- Oct 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light, Ultraviolet, Dermatological.
- Product code
- FTC
- FDA device class
- 2
FDA decision timeline
K262285 received
Application receipt date recorded by FDA.
K262285 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FTC
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Guangxi Hope Medical Devices Technology Co., Ltd. | 510(k) clearance | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shijiazhuang Recovery Star Medical Device Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shijiazhuang
Sources and methodology
- Original FDA record: K262285
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records